PD-Rx Pharmaceuticals, Inc. (PDRX)

Market Cap	5.48M +20.5%
Revenue (ttm)	18.35M -15.1%
Net Income	-257.52K
EPS	-0.16
Shares Out	1.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,411
Average Volume	1,453
Open	3.250
Previous Close	2.900
Day's Range	3.250 - 3.330
52-Week Range	2.410 - 3.330
Beta	1,657,732.22
RSI	58.29
Earnings Date	Nov 20, 2025

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to trac...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1986
• Employees: 28
• Stock Exchange: OTCMKTS
• Ticker Symbol: PDRX

Financial Performance

In fiscal year 2025, PD-Rx Pharmaceuticals's revenue was $18.35 million, a decrease of -3.15% compared to the previous year's $18.95 million. Losses were -$257,523, -65.82% less than in 2024.